Literature DB >> 3925553

Preparation of bispecific antibodies by chemical recombination of monoclonal immunoglobulin G1 fragments.

M Brennan, P F Davison, H Paulus.   

Abstract

Preparation of bispecific antibodies by the chemical reassociation of monovalent fragments derived from monoclonal mouse immunoglobulin G1 is inefficient because of side reactions during reoxidation of the multiple disulfide bonds linking the heavy chains. These side reactions can be avoided by using specific dithiol complexing agents such as arsenite and effecting disulfide formation with a thiol activating agent such as 5,5'-dithiobis(2-nitrobenzoic acid). In this way bispecific antibodies were obtained in high yield and free of monospecific contaminants from monoclonal mouse immunoglobulin G1 fragments. The bispecific antibodies were used as agents for the selective immobilization of enzymes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3925553     DOI: 10.1126/science.3925553

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  40 in total

1.  Increased antigen binding strengths of hybrid antibodies produced by human hybrid hybridomas.

Authors:  H Tachibana; S Shirahata; H Kawahara; H Murakami
Journal:  Cytotechnology       Date:  1991-09       Impact factor: 2.058

2.  Synthesis of bispecific antibodies using genetically encoded unnatural amino acids.

Authors:  Chan Hyuk Kim; Jun Y Axup; Anna Dubrovska; Stephanie A Kazane; Benjamin A Hutchins; Erik D Wold; Vaughn V Smider; Peter G Schultz
Journal:  J Am Chem Soc       Date:  2012-06-06       Impact factor: 15.419

Review 3.  Symmetry breaking: bispecific antibodies, the beginnings, and 50 years on.

Authors:  Gert Riethmüller
Journal:  Cancer Immun       Date:  2012-05-01

Review 4.  Investigational immunotherapeutics for B-cell malignancies.

Authors:  Alfonso Quintás-Cardama; William Wierda; Susan O'Brien
Journal:  J Clin Oncol       Date:  2010-01-04       Impact factor: 44.544

5.  Tumour-infiltrating lymphocytes in primary melanoma: functional consequences of differential IL-2 receptor expression.

Authors:  J C Becker; A Schwinn; R Dummer; G Burg; E B Bröcker
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

6.  Mammalian expression of single chain variable region fragments dimerized by Fc regions.

Authors:  T Kato; K Sato; S Suzuki; H Sasakawa; M Kurokawa; K Nishioka; K Yamamoto
Journal:  Mol Biol Rep       Date:  1995       Impact factor: 2.316

Review 7.  Bispecific antibody: a tool for diagnosis and treatment of disease.

Authors:  S Songsivilai; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

8.  Preparation and analysis of bifunctional immunoconjugates containing monoclonal antibodies OKT3 and BABR1.

Authors:  P D Foglesong; M A Winkler; J O Price; G D Marshall; S H Reagh; D A Bush; K S Hixson; W H West
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 9.  Bispecific Antibodies for the Treatment of Acute Myeloid Leukemia.

Authors:  Daniel G Guy; Geoffrey L Uy
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

Review 10.  Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells.

Authors:  William R Strohl; Michael Naso
Journal:  Antibodies (Basel)       Date:  2019-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.